Event ID # 895
Date:
Thursday, June 4, 2009
 Time:
5:00 pm - 7:00 pm (GMT)
Event:
ExL Pharma's From “HIPAA 1” to “HIPAA 2”
Host:
ExL Pharma
Contact:
Pam		 Phone:
Email:
info@exlpharma.com
Media Type:
Webinar
Website:
http://www.exlpharma.com/eventDetail.php?id=190

ExL Pharma
http://www.exlpharma.com/index.php
Price:
For info, please visit: http://www.exlpharma.com/eventPricing.php?id=190
Full details:

ATTEND THIS WEBINAR TO UNDERSTAND:

  • Changes to HIPAA enacted by ARRA
  • The implications of new health information privacy/security requirements for research sponsors, CROs and researchers
  • The potential operational, legal and other responses to regulations and guidance's to be promulgated over the next 6- 18 months

Webinar Summary:
The American Recovery and Reinvestment Act (ARRA) includes some $19 billion for health information technology (HIT), with a goal of having electronic health records (EHRs) available to every American by 2014. The bill also makes dozens of changes to HIPAA (the Health Insurance Portability and Accountability Act), extending certain privacy and security requirements to companies that collect and use individuals' health information, such as those that offer personal health records (PHRs) or conduct certain public health activities like facilitating the reporting of adverse events. This webinar explores the implications of these new requirements for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and researchers.

The passage of the ARRA has prompted many questions, including:
  • Will new privacy regulations make biomedical research - from clinical trials to outcomes studies - more difficult?
  • How will new security and breach reporting requirements impact patient recruitment programs and websites that gather health information as part of a 'personal health record'?
  • Will healthcare organizations allow researchers to access data sets in large databases for drug safety studies in the future?
  • Are pharmaceutical companies and CROs on the way to becoming “business associates” under HIPPA?
This webinar aims to address these questions and arm you with the information you need to know to prepare for changes impacting biopharmaceutical R&D starting later this year and continuing in through 2010.

FREE TO ACRO MEMBERS!
*If you are an ACRO member, please call Pam Sobotka at 703-865-4077, or email at psobotka@exlpharma.com, to receive your free registration

Who should Attend

This course has been designed to benefit VPs, Directors, Managers and Team Leaders at Pharmaceutical/ Biotech companies, CROs, Academic Research Organizations (AROs), Investigative Sites, and IRBs, working in the following departments:

  • Legal Counsel
  • Regulatory/Compliance
  • Privacy
  • Clinical Operations and R&D
  • Information Technology/Management
  • Data Management/Integration
  • Informatics/Bioinformatics
  • Database Operations/Services
  • Patient Recruitment
  • Safety/Pharmacovigilance
  • Health Outcomes